Investors/Media

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet need. Learn more about our clinical pipeline here.

Corporate Presentation

Stock Information

Change

High

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Events and Presentations

November 22, 2021 at 10:00 AM EST
Piper Sandler 33rd Annual Healthcare Conference Sign up
August 25, 2021 from 11:00 AM to 1:00 PM EDT
Virtual R&D Day Sign up